Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9K Buy
+18,889
New +$14.2K ﹤0.01% 3085
2025
Q4
Sell
-54,771
Closed -$74.5K 3057
2025
Q3
$74.5K Buy
+54,771
New +$82.9K ﹤0.01% 2692
2024
Q4
Sell
-310,360
Closed -$1.03M 2655
2024
Q3
$1.03M Sell
310,360
-195,154
-39% -$663K ﹤0.01% 1639
2024
Q2
$1.56M Buy
505,514
+343,692
+212% +$1.13M ﹤0.01% 1479
2024
Q1
$654K Buy
+161,822
New +$610K ﹤0.01% 1827
2022
Q4
Sell
-20,340
Closed -$202K 3015
2022
Q3
$202K Buy
+20,340
New +$184K ﹤0.01% 3079
2022
Q2
Sell
-122,503
Closed -$1.13M 3501
2022
Q1
$1.13M Buy
+122,503
New +$922K ﹤0.01% 2393

Other funds holding DCGO

Marshall Wace's DCGO Position: Q1 2026 in Review

Marshall Wace opened a new position in DocGo (DCGO) in Q1 2026: 18,889 shares worth $11.9K. The stake represents ﹤0.01% of the portfolio and ranks #3085 among its holdings. This is a return to the name: Marshall Wace previously reported a position in DCGO as recently as Q3 2025.

Marshall Wace first reported a position in DCGO in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.56M in Q2 2024. 122 funds tracked by Wall St. Rank hold DCGO as of Q1 2026.

  • Marshall Wace held 18,889 shares of DocGo worth $11.9K as of Q1 2026.
  • DocGo was a new Marshall Wace position in Q1 2026.
  • DocGo made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #3085 holding.
  • Marshall Wace first reported a position in DocGo in Q1 2022 and has held it in 7 quarters since.
  • Marshall Wace's DocGo position peaked at $1.56M in Q2 2024.
  • 122 funds tracked by Wall St. Rank held DocGo as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.